The FDA has previously approved the SGLT2 inhibitor in patients with HFrEF, but not HFmrEF or HFpEF

Although the vaccine maker previously cut expenses by $50 million without laying off staff, the measures were not enough to keep pace with the effects of the COVID-19 global health emergency. 

The company reported a Q1 revenue of $161.1 million, up 72% from Q1 in 2022. Both gross profit and net income were also up considerably when compared to 2022. 

The National Science Foundation (NSF) is setting up seven new institutes for studying foundational AI. Two of the initiatives have healthcare as a prime focus.

Talks between the two companies have reached a standstill, according to a new report. The rumor appears to have impacted the stock prices of both Boston Scientific and Shockwave Medical. 

New research presented at the 103rd Annual Meeting of the American Association for Thoracic Surgery examined the lack of diversity seen in this important specialty. 

Samsung's smartwatches, already equipped with ECG technology, will now be able to alert users when signs of an irregular heart rhythm are detected. 

Pioneering cardiologist James Muller, MD, a winner of the Nobel Peace Prize, was one of the chief researchers that developed the concept of vulnerable plaques causing heart attacks. He was recently honored by the American College of Cardiology for his contributions.